1. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart;Bottino;Progress in Biophysics and Molecular Biology,2006
2. Multiscale modelling of drug-induced effects on cardiac electrophysiological activity;Brennan;European Journal of Pharmaceutical Sciences,2009
3. Comprehensive in vitro proarrhythmia assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: A visionary 21st century initiative;Cavero;Expert Opinion on Drug Safety,2014
4. Drugs and life-threatening ventricular arrhythmia risk: Results from the DARE study cohort;Coughtrie;BMJ Open,2017
5. An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment;Davies;American Journal of Physiology. Heart and Circulatory Physiology,2012